Table 2. Recommended tools and approaches to identify the patient clusters in clinical practice.
| Cluster identification approaches |
Attitudinal–Control Cluster |
||||
|---|---|---|---|---|---|
| Well-adjusted | Rejectors | Endurer | Lost | Worrier | |
| Validated typing tool | ✓ | ✓ | ✓ | ✓ | ✓ |
| Consultation skills | ✓ | ✓ Open, non-judgmental, non-paternalistic attitude to allow patients to share their misgivings/doubts/reasons for denial | ✓ | ✓ | ✓ Risk profile and understand concerns |
| Asthma control assessment (ACT, ACQ, RCP3, GINA-based symptom control assessment) | ✓ | ✓ | ✓ | ✓ | ✓ |
| Exacerbation history/risk assessment | ✓ | ✓ | ✓ | ✓ | ✓ |
| FeNO | ✓ | × | × | ✓ | ✓ |
| Assessment of access to healthcare | ✓ | × | × | × | × |
| Lung function testing (spirometry, peak flow) | ✓ | ✓ | ✓ | ✓ | × |
| Beliefs about Medicines Questionnaire (BMQ) | × | ✓ | ✓ | ✓ | ✓ |
| Morisky Medication Adherence Scale (MMAS) | × | ✓ | ✓ | × | ✓ |
| Quality of life assessment (AQLQ) | × | ✓ | ✓ | ✓ | ✓ |
| Assess medication-related adverse events | × | × | ✓ | ✓ | × |
| Dysfunctional breathing assessment | × | × | × | ✓ | ✓ |
| Hospital Anxiety and Depression Score (HADS) | × | × | × | ✓ | ✓ |
| Inhalation technique assessment | × | ✓ | × | × | ✓ |
| Induced sputum analysis | ✓ | × | × | × | × |
| Medication history review | ✓ | × | × | × | × |
| Assessment of patient's perceived self-efficacy | × | × | ✓ | × | × |
| Comorbidity Assessment | × | × | × | ✓ | × |
✓, specifically recommended for this patient group by the expert panel.
×, not specifically recommended for this patient group by the expert panel.